Neuroscientific Biopharmaceuticals is an Australian public listed company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurodegenerative conditions and diseases of the eye that have high unmet medical need.
Our vision is to transform how the pharmaceutical industry approaches the understanding and treatment of neurodegenerative disease such as Alzheimer’s Disease.
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Our vision is to transform how the pharmaceutical industry approaches the understanding and treatment of neurodegenerative disease such as Alzheimer’s Disease.
We believe that no other disease area holds as much need or as much promise for medical breakthroughs as neuroscience.
Ticker:
NSB
Exchange:
ASX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Australia
Year Founded:
2016
Main Therapeutic Focus:
CNS/Neurological
Lead Product in Development:
EmtinB - an LRP-1 agonist
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
1
Speaker
